Xinhua Yang

5.1k citations
32 papers · 754 indexed · h-index 15
Topics
Breast Cancer Treatment Studies (6 papers)Breast Lesions and Carcinomas (5 papers)Cancer-related molecular mechanisms research (4 papers)
Partner nations
ChinaUnited StatesCanada

In The Last Decade

Xinhua Yang

30 papers receiving 746 citations

Peers

Xinhua Yang
Comparison fields: 5 of 85
  • Molecular Biology 431
  • Plant Science 265
  • Cancer Research 194
  • Oncology 120
  • Pathology and Forensic Medicine 78
Replace Laura Schramm with:
Laura Schramm United States
Yan Zhu China
Yuri Takeda Japan
Conghua Xie China
Dengke Li China
Seiya Saito Japan
Sandra Louzada United Kingdom
Qi Shi China
Jocelyne Michelon France
Xinhua Yang relative to Laura Schramm United States Laura Schramm's profile →
Citations per field
00.5×3.6×
Laura Schramm · 1×
Citations per year

Countries citing papers authored by Xinhua Yang

Since Specialization
Citations

This map shows the geographic impact of Xinhua Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinhua Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinhua Yang more than expected).

Fields of papers citing papers by Xinhua Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinhua Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinhua Yang. The network helps show where Xinhua Yang may publish in the future.

Co-authorship network of co-authors of Xinhua Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Xinhua Yang. A scholar is included among the top collaborators of Xinhua Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinhua Yang. Xinhua Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 14
4 10
5 25
6 18
7 4
8 8
9 6
10 30
11 46
12 308
13 36
14 16
15 61
16 1
17 19
18 25
19 27
20 16

About Xinhua Yang

Xinhua Yang is a scholar working on Cancer Research, Pathology and Forensic Medicine and Energy Engineering and Power Technology, having authored 32 papers that have together received 754 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (6 papers), Breast Lesions and Carcinomas (5 papers) and Cancer-related molecular mechanisms research (4 papers). The work is most often cited by research in Cancer Research (194 citations), Plant Science (265 citations) and Molecular Biology (431 citations). Xinhua Yang has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Sebastian Reyes-Chin-Wo, María José Truco, Yidong Wang, Siwaret Arikit, Richard W. Michelmore, Shilin Zhu, Alexander Kozik, Chunyan Xu, Blake C. Meyers and Xun Xu. Their work appears in journals such as Nature Communications, PLoS ONE and Journal of Agricultural and Food Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026